The Cooper (The Cooper) Operating Income

: $537 Mil (TTM As of Jan. 2024)

View and export this data going back to 1983. Start your Free Trial

The Cooper's Operating Income for the three months ended in Jan. 2024 was $153 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jan. 2024 was $537 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. The Cooper's Operating Income for the three months ended in Jan. 2024 was $153 Mil. The Cooper's Revenue for the three months ended in Jan. 2024 was $932 Mil. Therefore, The Cooper's Operating Margin % for the quarter that ended in Jan. 2024 was 16.43%.

Warning Sign:

The Cooper Companies Inc operating margin has been in a 5-year decline. The average rate of decline per year is -3.2%.

The Cooper's 5-Year average Growth Rate for Operating Margin % was -3.20% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. The Cooper's annualized ROC % for the quarter that ended in Jan. 2024 was 3.61%. The Cooper's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 25.43%.

The Cooper Operating Income Historical Data

The historical data trend for The Cooper's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Operating Income

528.10

311.80

505.80

507.60

533.10

The Cooper Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Operating Income																149.50	96.30	151.60	135.70	153.10

The Cooper Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $537 Mil.

The Cooper (NAS:COO) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

The Cooper's annualized ROC % for the quarter that ended in Jan. 2024 is calculated as:

	ROC % (Q: Jan. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Oct. 2023 )	+	Invested Capital (Q: Jan. 2024 ))	/ count )
=	612.4 * ( 1 - 32.33% )	/	( (11276.2	+	11695.1)	/ 2 )
=	414.41108	/	11485.65
=	3.61 %

where

	Invested Capital		(Q: Oct. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	11658.9	-	261.9	-	( 120.8	-	max(0, 969	-	1704.9	+	120.8	))
=	11276.2

	Invested Capital		(Q: Jan. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	12032.6	-	202.3	-	( 135.2	-	max(0, 964.9	-	1793.9	+	135.2	))
=	11695.1

Note: The Operating Income data used here is four times the quarterly (Jan. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

The Cooper's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jan. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Oct. 2023		Q: Jan. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	599.6	/	( ( (1632.6 + max(660.5, 0))	+	(1682.2 + max(739.9, 0)) )	/	2 )
=	599.6	/	( ( 2293.1	+	2422.1 )	/	2 )
=	599.6	/	2357.6
=	25.43 %

where Working Capital is:

	Working Capital		(Q: Oct. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(609.7	+	735.6	+	238.8)	-	(261.9	+	123.6	+	538.1)
=	660.5

	Working Capital		(Q: Jan. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(651	+	747.5	+	260.2)	-	(202.3	+	122.4	+	594.1)
=	739.9

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

The Cooper's Operating Margin % for the quarter that ended in Jan. 2024 is calculated as:

Operating Margin %	=	Operating Income (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	153.1	/	931.6
	=	16.43 %

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

The Cooper Operating Income Related Terms

Thank you for viewing the detailed overview of The Cooper's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cooper (The Cooper) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (NAS:COO) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

COO:Mexico CP6:Germany C1OO34:Brazil

Address

6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583

Website

https://www.coopercos.com

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

Executives

Gary S Petersmeyer	director	3400 CENTRAL AVENUE, SANTA CLARA CA 95051
Robert S Weiss	director, officer: EVP and CFO	6140 STANERIDGE MALL RES #590, PLEASSANTON CA 94503
Agostino Ricupati	officer: Sr. VP, Finance & Tax	C/O THE COOPER COMPANIES, INC., 6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
Warner Gerard H Iii	officer: President, CooperVision, Inc.	C/O COOPER COMPANIES INC., 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON CA 94583
Jody S Lindell	director	2536 FILLMORE ST., SAN FRANCISCO CA 94115
Cynthia L Lucchese	director	7966 N. ILLINOIS STREET, INDIANAPOLIS IN 46260
Nicholas Khadder	officer: VP, General Counsel & Corp Sec	2836 JOHNSON AVENUE, ALAMEDA CA 94501
Daniel G Mcbride	officer: VP and Senior Counsel	5 EL CORTE, ORINDA CA 94563
Brian G Andrews	officer: Treasurer	4300A 17TH STREET, SAN FRANCISCO CA 94114
Maria Rivas	director	C/O MEDIDATA SOLUTIONS, INC., 350 HUDSON STREET, 9TH FLOOR, NEW YORK NY 10014
White Albert G Iii	officer: VP & Treasurer	6790, SPRINGDALE COURT, VICTOR NY 14564
Teresa S Madden	director	414 NICOLLET MALL, MINNEAPOLIS MN 55401
Robert D Auerbach	officer: President, CSI	C/O THE COOPER COMPANIES, INC., SUITE 590, PLEASANTON CA 94588
Holly R Sheffield	officer: EVP, CSO	C/O THE COOPER COMPANIES, INC., 6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
Mark J Drury	officer: VP, General Counsel & Sec.	C/O COOPERCOMPANIES, 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON CA 94583